In the TRISCEND II trial, a total of 400 patients with severe symptomatic tricuspid regurgitation were randomized in a 2:1 ratio to undergo either transcatheter tricuspid valve replacement with medical therapy (valve-replacement group) or medical therapy alone (control group).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transplantation
October 31, 2024
The role of transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis in the pre- and post-lung transplant population is limited. This specific patient population is considered high risk for general anesthesia and for surgical aortic valve replacement.
January 23, 2024
Interesting conclusion on superiority of CRT over ICD
July 20, 2023
This study aimed to determine if socioeconomic status and region had any effect on post-transplant outcomes across different races and ethnicities. After another study found that transplant outcomes varied greatly based on multiple factors, researchers wanted to know if socioeconomic factors played into differences based on race.
July 15, 2022
In this article, the authors provide an expert opinion on the developments, current landscape, and direction in which ex vivo lung perfusion will undertake.
April 28, 2021
This study assessed the impact of frailty in patients with advanced heart failure on clinical outcomes after heart transplantation (HTx).
July 14, 2020
A small histopathological study of SARS and influenza autopsies compared to rejected for transplantation lungs. There is some speculation on the popular procoagulopathic nature of the panvirus, based on expression of angiotensin converting enzyme 2.There might be a collateral stimulus for lung preservation in organ retrieval.
April 16, 2020
The UNOS donor heart allocation system was revised in 2018, giving priority to patients on inpatient mechanical circulatory support (MCS). Patients admitted with heart failure-associated cardiogenic shock were tracked for the frequency of use of mechanical circulatory support before and after implementation of this change. In non-transplant center
April 2, 2020
Quite refreshing well-written experimental paper leaving promises of artificial organoids.
December 19, 2019
Donor lungs undergoing EVLP were more injured, but long-term outcomes of transplant were similar between EVLP and non-EVLP lungs, including the incidence of graft dysfunction and survival.